Contracts › 75N93018C00025
75N93018C00025: Igf:Ot::Igf - Advanced Development and Clinical Evaluation of a Synthetic Intranasal Entamoeba Histolytica Vaccine Containing Adjuvant.
Awarded to Access to Advanced Health Institute by National Institutes of Health (NIH).
$10.8Mobligated
$18.4Mpotential value
31 August 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93018C00025 |
|---|---|
| Awardee | Access to Advanced Health Institute |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | WA |
| Offers received | 24 |
| Period of performance | 21 September 2018 to 31 August 2026 |
| Potential end | 31 August 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record